Ilian Iliev, Managing Director of EMV Capital, invests primarily in early-stage deep tech and life sciences. See sector focus and contact routes.
Ilian Iliev, Managing Director of EMV Capital, invests primarily in **early-stage deep tech and life sciences** companies, focusing on **pre-Series A** startups as well as strategic restarts, pivots, and turnarounds in the UK and internationally [3][7]. His firm targets IP-led sectors including **digital health, satellite communications, sustainability, robotics, and antibiotic resistance**, prioritizing validated technology with strong intellectual property and clear value milestones [2][6]. A distinctive aspect of Iliev’s thesis is EMV’s **venture-building model**, which combines investment with corporate finance and active value creation services—such as talent placement and corporate connections—to accelerate growth, exemplified by portfolio successes like **Martlet Capital** (2.5x return) and the acquisition of **Destiny Pharma’s** antimicrobial resistance assets [2][7][8].
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in London.
Investors like Ilian Iliev · Full investor directory · Investor access · Company funding database